Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Cai

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Journal of Medicinal Chemistry|March 20, 2026
Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid TumorsTingting Yang, Ting Wei, Shiyang Sun, et al.
Journal of Hematology & Oncology|September 1, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradationPengyun Li, Xiaotong Hu, Zhiya Fan, et al.
Journal of Medicinal Chemistry|April 7, 2026
Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer ImmunotherapyYalei Wang, Zhenze Qi, Shiyang Sun, et al.
British Journal of Pharmacology|June 22, 2019
Lovastatin attenuates hypertension induced by renal tubule-specific knockout of ATP-binding cassette transporter A1, by inhibiting epithelial sodium channelsMing-Ming Wu, Chen Liang, Xiao-Di Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Anti-CTLA-4 m2a Antibody Exacerbates Cardiac Injury in Experimental Autoimmune Myocarditis Mice By Promoting Ccl5-Neutrophil InfiltrationMing-Ming Wu, Yan-Chao Yang, Yong-Xu Cai, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Journal of Medicinal Chemistry|March 20, 2026
Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid TumorsTingting Yang, Ting Wei, Shiyang Sun, et al.
Journal of Hematology & Oncology|September 1, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradationPengyun Li, Xiaotong Hu, Zhiya Fan, et al.
Journal of Medicinal Chemistry|April 7, 2026
Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer ImmunotherapyYalei Wang, Zhenze Qi, Shiyang Sun, et al.
British Journal of Pharmacology|June 22, 2019
Lovastatin attenuates hypertension induced by renal tubule-specific knockout of ATP-binding cassette transporter A1, by inhibiting epithelial sodium channelsMing-Ming Wu, Chen Liang, Xiao-Di Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Anti-CTLA-4 m2a Antibody Exacerbates Cardiac Injury in Experimental Autoimmune Myocarditis Mice By Promoting Ccl5-Neutrophil InfiltrationMing-Ming Wu, Yan-Chao Yang, Yong-Xu Cai, et al.
Pageof 31